ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,450 | -29.5% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $3,475 | -12.6% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,975 | -74.5% | 2,500 | 0.0% | 0.00% | -75.0% |
| Q4 2022 | $15,575 | -8.4% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $17,000 | +6.2% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $16,000 | +33.3% | 2,500 | 0.0% | 0.00% | +33.3% |
| Q1 2022 | $12,000 | -7.7% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $13,000 | -56.7% | 2,500 | 0.0% | 0.00% | -57.1% |
| Q3 2021 | $30,000 | -43.4% | 2,500 | 0.0% | 0.01% | -36.4% |
| Q2 2021 | $53,000 | -24.3% | 2,500 | 0.0% | 0.01% | -35.3% |
| Q1 2021 | $70,000 | +7.7% | 2,500 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $65,000 | -36.3% | 2,500 | -8.8% | 0.02% | -43.3% |
| Q3 2020 | $102,000 | +750.0% | 2,740 | +1041.7% | 0.03% | +650.0% |
| Q2 2020 | $12,000 | +50.0% | 240 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $8,000 | -42.9% | 240 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $14,000 | +55.6% | 240 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $9,000 | -18.2% | 240 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $11,000 | +10.0% | 240 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $10,000 | -9.1% | 240 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $11,000 | – | 240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
| Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
| Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
| BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
| Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
| PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
| Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
| Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
| Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
| SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |